BridgeBio CEO Neil Kumar disposes of common shares worth $691,023.06
BridgeBio Pharma CEO Neil Kumar sold 10,000 shares of common stock on Sept. 17, 2026. Sales priced at USD 69.01 to USD 69.57 per share. * Holdings via the Kumar Haldea Family Irrevocable Trust fell to 495,686 shares following the transactions. Disclaimer: This news brief was created by Public Technologies (PUBT) using